[EN] INHIBITORS OF MSBA AS ANTIBIOTICS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF [FR] INHIBITEURS DE MSBA EN TANT QU'ANTIBIOTIQUES, COMPOSITIONS PHARMACEUTIQUES ET LEURS UTILISATIONS
摘要:
The present disclosure is directed to certain functionalized dual substituted arene derivatives (e.g., arenesulfonamide, arenesulfamide, areneoxalamide and areneamide derivatives) of Formula I: and pharmaceutically acceptable salts thereof, wherein X1, X2, Y, Z, G, R1, R2, R3, R4, and R5are as defined herein, which are potent inhibitors of MsbA and may be useful in the treatment of infections caused by any multi-drug resistant (MDR) Gram-negative bacteria. The disclosure is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the treatment of infections in which MsbA is involved.
methods for the compound are simple and direct, but are not effective for the direct synthesis of indoloquinazolinone with a methylene group at the C‐6 position. A palladium(0)‐catalyzed cyclization of chloroquinazolinone viaCHfunctionalization was developed for a concise synthesis of indoloquinazolinone derivatives. The presence of a substituent at the C‐6 position is important for obtaining the